The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma
2017 ◽
Vol 3
(3)
◽
pp. 102-106
◽
2016 ◽
Vol 11
(6)
◽
pp. 789-800
◽
2018 ◽
Vol 13
(4)
◽
pp. S43
◽
2019 ◽
2018 ◽
Vol 35
(1)
◽
pp. 591-598
◽
2015 ◽
Vol 51
◽
pp. S644
◽
Keyword(s):
2017 ◽
Vol 98
(1)
◽
pp. 223
◽